PulseAugur
EN
LIVE 23:57:11
ENTITY retatrutide

retatrutide

PulseAugur coverage of retatrutide — every cluster mentioning retatrutide across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_184624 ·

    Eli Lilly's Obesity Drugs Fuel 48% Revenue Growth, Retatrutide Trials Show Promise

    Eli Lilly and Company reported a significant increase in its second-quarter revenue, reaching $23 billion, a 48% year-over-year growth. This surge was primarily driven by its GLP-1 drugs, Mounjaro and Zepbound, which ge…